Kilroy Signs First Tenant to Second Phase of Oyster Point
Kilroy Realty has secured a 24,000-square-foot lease at Kilroy Oyster Point Phase 2 (KOP 2), its expansive life science development in South San Francisco. The first tenant for this phase is Color Health, a leader in cancer detection, which will establish a new genomics lab at the site. The lab is part of Kilroy’s spec suite initiative designed to attract innovative life science companies.
“We are thrilled to welcome Color to Kilroy Oyster Point Phase 2, with occupancy commencing early next year,” said Angela Aman, CEO of Kilroy. “This announcement underscores KOP 2’s resonance with discerning life science tenants and exciting leasing momentum. We remain on track to achieve 100,000 square feet of executed leases at the project by year-end and expect KOP 2 to be a key growth driver for the company in the years ahead.”
Kilroy Oyster Point Phase 2 is a purpose-built life science campus comprising three buildings and totaling approximately 875,000 square feet. It is part of the broader five-phase Oyster Point development, which spans a 50-acre waterfront site in South San Francisco.
Industry leaders from CommonSpirit, Meridian, Adventist Health, and Anchor Health will be sharing insights on the future of healthcare real estate at Connect Healthcare Real Estate, taking place October 14–15 in Irvine.
